I read it was in phase 2/3.
Result was announce on Feb 20 and has another 18 months to g o from that month in a 36 month trial
Just announced results for HD study. 34% reduction in disease progression! Significant improvement in total motor score on a long term test. Good safety profile. Investigators in France want this drug ASAP for those receiving it in trials. Raptor will meet with Government agencies to discuss the next step toward approval for HD drug. Other pipelines for Nash disease and Leigh syndrome progressing well. Overall, very good news!
There are three conferences being attended by Raptor Pharmaceutical in the next week or so. Is anybody able to comment on whether there will be news or updates on the current trials underway and their progress? Any opinions would be welcome. The stock is moving up as if something is being anticipated next week.
Great call Magnu, What other great stock advise can you share with us today. I would like to jump on them before they move up as well as RPTP is doing this morning. Not a bad start to the day IMO.
noj, finally got above $9 and holding. It is hard to get information and it does not look as if any interim data is due soon. If you, or anyone has information to the contrary please post it.
noj, I have looked to see if any scheduled release of data from an ongoing trial. Maybe some interim positive data on HD will be forthcoming but other than that nothing I can see. Huge short interest on this stock could lead to a squeeze if something comes out positive.